Copyright © 2021. Inderes Oyj. All rights reserved.

Carasent ASA

Analyytikko

Sisäpiirin kaupat

Nettovaikuttavuus

Muut analyysit
16.6.
2022

Redeye comments on the news of Daniel Öhman being appointed as the new CEO of Carasent, following Dennis Höjer's decision to step down earlier this year. Mr. Öhman is currently the CEO of GHP Speciality Care.

Tiedotteet
16.6.
2022
June 16, 2022

The board of directors of Carasent ASA ("Carasent" or "the Company") has today
appointed Daniel Öhman as the Company's new Chief Executive Officer (CEO). He
will succeed Dennis Höjer who has been CEO since December 2020. Öhman will start
no later than 2 January 2023.

Daniel Öhman is at present CEO of GHP Speciality Care, a role he has held since
2013. During Öhman's leadership, GHP Specialty Care's valuation increased from
370 MSEK to 2 450 MSEK, turnover doubled, and EBITDA increased from 50 MSEK to
200 MSEK.
Muut analyysit
20.5.
2022

Redeye updates its estimates following Carasent’s Q1 report and comments on topics ranging from the heavy capex cycle to CEO Dennis Höjer’s decision to step down.

Tiedotteet
20.5.
2022

Redeye updates its estimates following Carasent’s Q1 report and comments on topics ranging from the heavy capex cycle to CEO Dennis Höjer’s decision to step down. We expect Webdoc NO to be launched in Q2 2022 and its launch and successive ramp-up will be a litmus test for the Webdoc platform and the current spending levels.

Read more and download the Research Update.

Tiedotteet
28.4.
2022
Attached please find Minutes from today's Annual Shareholder Meeting, with
attachment.

All items on the agenda was resolved as prosposed in the Calling Notice.

For further information, please contact Johan Lindqvist, Chairman of the Board
phone: + 46 73 355 0935.
Muut analyysit
28.4.
2022

Redeye comments on Carasent’s Q1 report, which was solid albeit somewhat below our sales estimates. Margins and customer intake were in line.

Tiedotteet
28.4.
2022
Attached please find Carasent ASA Q1 2022 Financial Result Presentation.

For further information, please contact
CFO Svein Martin Bjørnstad, tel: 47 979 69 493
Tiedotteet
28.4.
2022
Attached please find release regarding CEO Dennis Højer stepping down.

For further information, please contact the
Chairman of the Board Johan Lindqvist,
tel: + 46 73355 0935.
Tiedotteet
28.4.
2022
Attached please find Carasent ASA Financial Report for Q1/2022.

For further information, please contact
CFO Svein Martin Bjørnstad, tel: 47 979 69 493
Tiedotteet
25.4.
2022
Carasent ASA will present its Q1, 2022 Financial Results as a webcast on April
28, at 8:00 a.m.

Please use the following link for the webcast:

https://channel.royalcast.com/landingpage/hegnarmedia/20220428_2/

Carasent ASA